UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Link zum Volltext

Verfügbarkeit prüfen

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Human pathology, 2015-11, Vol.46 (11), p.1670-1678

2015

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

Human pathology, 2018-02, Vol.72, p.160-166

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study

Human pathology, 2014-07, Vol.45 (7), p.1529-1540

2014

Link zum Volltext

Verfügbarkeit prüfen

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

Human pathology, 2010, Vol.41 (1), p.20-25

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors in malignant pleural mesothelioma

Human pathology, 2015-06, Vol.46 (6), p.789-804

Davidson, Ben, MD, PhD

2015

Link zum Volltext

Verfügbarkeit prüfen

D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma

Human pathology, 2005-04, Vol.36 (4), p.372-380

ORDONEZ, Nelson G

2005

Link zum Volltext

Verfügbarkeit prüfen

The use of insulin like-growth factor II messenger RNA binding protein–3 in diagnostic pathology

Human pathology, 2011-03, Vol.42 (3), p.303-314

2011

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor II messenger RNA–binding protein 3 expression in gastrointestinal mesenchymal tumors

Human pathology, 2014-03, Vol.45 (3), p.481-487

2014

Link zum Volltext

Verfügbarkeit prüfen

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma

Human pathology, 2013-09, Vol.44 (9), p.1859-1866

2013

Link zum Volltext

Verfügbarkeit prüfen

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

Human pathology, 2007, Vol.38 (1), p.1-16

ORDONEZ, Nelson G

2007

Link zum Volltext

Verfügbarkeit prüfen

IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology

Human pathology, 2010-05, Vol.41 (5), p.745-750

2010

Link zum Volltext

Verfügbarkeit prüfen

Latent TGF- β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor- β activity in malignant mesothelioma

Human pathology, 2011-02, Vol.42 (2), p.269-278

2011

Link zum Volltext

Verfügbarkeit prüfen

Mesothelin ( MSLN ) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter

Human pathology, 2010-09, Vol.41 (9), p.1330-1338

2010

Link zum Volltext

Verfügbarkeit prüfen

Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child

Human pathology, 2013-04, Vol.44 (4), p.664-669

2013

Link zum Volltext

Verfügbarkeit prüfen

The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: A comparative study

Human pathology, 2004-06, Vol.35 (6), p.697-710

ORDONEZ, Nelson G

2004

Link zum Volltext

Verfügbarkeit prüfen

Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma

Human pathology, 2007-07, Vol.38 (7), p.986-994

2007

Link zum Volltext

Verfügbarkeit prüfen

Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas

Human pathology, 2005-11, Vol.36 (11), p.1163-1167

ORDONEZ, Nelson G

2005

Link zum Volltext

Verfügbarkeit prüfen

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma

Human pathology, 2003-11, Vol.34 (11), p.1155-1162

2003

Link zum Volltext

Verfügbarkeit prüfen

Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

Human pathology, 1999-06, Vol.30 (6), p.695-700

1999

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions

Human pathology, 2009-04, Vol.40 (4), p.527-537

2009

Link zum Volltext

Verfügbarkeit prüfen

Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases

Human pathology, 2005-05, Vol.36 (5), p.465-473

ORDONEZ, Nelson G

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical diagnosis of epithelioid mesotheliomas: A critical review of old markers, new markers

Human pathology, 2002-10, Vol.33 (10), p.953-967

ORDONEZ, Nelson G

2002

Link zum Volltext

Verfügbarkeit prüfen

Ultrastructural features of diffuse malignant mesotheliomas

Human pathology, 1998-12, Vol.29 (12), p.1382-1392

1998

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

Human pathology, 1997-06, Vol.28 (6), p.641-645

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

PublikationsformNewsletter-Artikel

Zeitschrift / SerieHuman Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Life Sciences & Biomedicine
(42)
Pathology
(42)
Science & Technology
(42)
Mesothelioma - Metabolism
(37)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Immunohistochemistry
(25)
Mesothelioma - Pathology
(25)
Lung Neoplasms - Metabolism
(20)
Mesothelioma - Diagnosis
(20)
Diagnosis, Differential
(19)
Female
(19)
Mesothelioma
(17)
Lung Neoplasms - Pathology
(15)
Adenocarcinoma - Metabolism
(14)
Pleural Neoplasms - Metabolism
(14)
Tumors
(14)
Investigative Techniques, Diagnostic Techniques
(13)
Male
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB-NALI5-00465 Elsevier Archive NL
(44)
MEDLINE
(44)
IngentaConnect
(44)
ScienceDirect Journals (5 years ago - present)
(44)
Single Journals
(44)
IngentaConnect Journals
(16)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

Prognostic factors in malignant pleural mesothelioma

D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma

The use of insulin like-growth factor II messenger RNA binding protein–3 in diagnostic pathology

Insulin-like growth factor II messenger RNA–binding protein 3 expression in gastrointestinal mesenchymal tumors

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology

Latent TGF- β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor- β activity in malignant mesothelioma

Mesothelin ( MSLN ) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter

Peripheral lymphadenopathy as the initial manifestation of malignant mesothelioma in a child

The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: A comparative study

Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma

Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma

Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions

Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases

Immunohistochemical diagnosis of epithelioid mesotheliomas: A critical review of old markers, new markers

Ultrastructural features of diffuse malignant mesotheliomas

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

Aktive Filter

Suchergebnisse filtern